Alzheimer’s Disease marker identified in theye

3 01 2013

Alzheimer’s Disease marker identified in theye

Cognoptix has developed SAPPHIRE II, a drug/device system that identifies Alzheimer’s Disease in the human lens when a patient consumes an identifying ophthalmic ointment.  Currently there is no early-stage non-invasive diagnostic for Alzheimer’s disease in the market.

Advertisements

Actions

Information

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s